FY21 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- FDABAA-21-00123
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Place of performance
- MD 20993, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration seeks research and development proposals through its Broad Agency Announcement for Advanced Regulatory Science for fiscal year 2021. Proposals are requested across eight areas of regulatory science to modernize toxicology, stimulate clinical innovation, support manufacturing, evaluate emerging technologies, harness data science, implement food safety systems, facilitate medical countermeasures, and strengthen social and behavioral research. Proposals will undergo scientific peer review based on technical merit, with multiple awards anticipated subject to available funding and a deadline of January 28, 2021 for submission.
There is no set-aside designation specified. Proposals are sought under PSC code AJ11 for regulatory science activities to be conducted in Silver Spring, Maryland as a renewal of a prior year BAA. As indefinite delivery/indefinite quantity contracts, the BAA does not provide defined periods of performance or pricing terms but rather aims to facilitate ongoing research supporting FDA regulatory functions on an as-needed basis. A subcontracting plan is required to ensure equitable small business participation in accordance with regulations.
Notice text
2 versions
Update #2 · Latest ·
January 28, 2021 - Amendment 1 to FDABAA-21-00123 has been posted to provide updated contact details for the ongoing administration of the BAA. White Papers must still be submitted to the same general FDABAA inbox as specified in the announcement, and all other submission requirements remain unchanged and unaffected by this amendment. All other terms, conditions and provisions of FDABAA-21-00123 remain unchanged.
*********************************************************
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas of interest defined within the BAA which serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
*This announcement is a renewal of the prior-year FY20 announcement (FDABAA-20-00123) and will remain open until further notice. This announcement is renewed on an annual basis.
Update #1 ·
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas of interest defined within the BAA which serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
*This announcement is a renewal of the prior-year FY20 announcement (FDABAA-20-00123) and will remain open until further notice. This announcement is renewed on an annual basis.
Files
| File | Type | Posted |
|---|---|---|
| FDABAA-21-00123.pdf | ||
| HHS SubK Plan Template.doc | DOC document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| FY21 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science | Award Notice | |
| This notice | Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity